Age had little effect on gene-silencing RNA activity in mice
One dose reduced target gene messages by more than 70% versus controls in several brain regions of both young and aged mice.
Our read
Interventions- Studied:
- Experiments in young and aged mice, two weeks, against controls
- What changed:
- Target gene messages fell by more than 70% in both young and aged mice compared with controls
- The catch:
- Reductions in gene messages were molecular outcomes, not evidence of improved symptoms or slower disease
- Why it’s aging research:
- It studies organisms or tissues that aged naturally.
Editor of record: Boris Djordjevic · AgingResearch.News
In an animal experiment, researchers tested a fat-linked RNA compound in 3-month-old and 21-month-old mice. The compound used small interfering RNA, molecules that reduce specific gene messages. Researchers gave a single 15-nanomole dose into the brain’s fluid-filled chambers and measured gene silencing two weeks later.
The compound reduced messages used to make huntingtin, a protein relevant to Huntington’s disease, by more than 70% in both age groups compared with controls. This occurred in brain regions called the cortex, hippocampus and striatum. Separate delivery tests found broadly similar distribution through the brain and spinal cord at both ages. Overall, age had minimal impact on the compound’s delivery and gene-silencing activity.
Why it matters
Aging alters the flow and clearance of fluid around the brain. Understanding whether those changes affect RNA delivery matters for developing medicines for neurodegenerative diseases.
Caveats
Reductions in gene messages were molecular outcomes, not evidence of improved symptoms or slower disease. These experiments were in mice, not people.
The paper
Vanderbilt University
Molecular Therapy, Jun 15, 2026, Open access
Comments
Be the first to comment.